Stroke Management—Personalized Diagnostic, Therapy and Rehabilitation

Dear Colleagues,

Stroke management has advanced considerably in recent decades, although there remain opportunities to further enhance outcomes via personalized and precision medicine approaches. Some key points in the background and history of this topic are as follows: the heterogeneity of stroke, personalized medicine, the Human Genome Project, advances in imaging, biomarkers, and omics technologies, wearables and telemedicine, AI and machine learning techniques. Recent studies have provided proof-of-concept for elements of precision stroke care while highlighting the need for further research and translation into standard clinical practice.

We look forward to contributions that showcase the immense potential to enhance the standard of care and outcomes across the many facets of stroke management via emerging precision and personalized medicine approaches.

This Special Issue seeks to showcase high-quality research focused on personalized and precision medicine approaches across the spectrum of stroke management, from rapid and accurate diagnostics to targeted therapies and tailored rehabilitation plans. We welcome original research as well as review articles that synthesize the state of the art in using patient-specific biomarkers, genetics, and other factors to achieve optimal outcomes in stroke care.

• Precision diagnostics for ischemic vs. haemorrhagic stroke;
• Imaging and biomarkers to identify salvageable tissue;
• Genomics and stroke risk prediction;
• Pharmacogenomics to predict drug efficacy/side effects;
• Personalized selection of thrombolytic and neuroprotective agents;
• Targeted rehabilitation programs based on functional deficits;
• Wearables and telemedicine for individualized post-stroke monitoring;
• Machine learning applications in tailored stroke management.

This Special Issue aims to spotlight innovations in precision medicine to address the heterogeneity inherent in stroke populations. We hope to assemble a body of work that captures the state of the art in this field while inspiring further advancements towards truly personalized stroke care.

Dr. Wenjun Tu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• stroke
• personalized medicine
• diagnostic
• therapy and rehabilitation